Answers are grounded in this paper and cite their sources.
Demonstrates that Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma, suggesting new therapeutic options.
The BDNF/TrkB axis promotes the progression of ESCC PNI, and Deguelin inhibits ESCC PNI by targeting this axis, enhancing the understanding of PNI's molecular mechanisms and offering new therapeutic options.
No takes yet. Share an insight, caveat, or question.
WEI et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: